SUMOylation of AhR modulates its activity and stability through inhibiting its ubiquitination

Journal of Cellular Physiology

Volumn 227, Issue 12, 2012, Pages 3812-3819

  Xing, Xinrong ^a   Bi, Hailian ^a   Chang, Alan K ^a   Zang, Ming Xi ^b   Wang, Miao ^a   Ao, Xiang ^a   Li, Shen ^a   Pan, Hongming ^a   Guo, Qianping ^a   Wu, Huijian ^a  

^a DALIAN UNIVERSITY OF TECHNOLOGY   (China)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ARGININE; AROMATIC HYDROCARBON RECEPTOR; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR;

ARTICLE; CELL STRAIN MCF 7; CONTROLLED STUDY; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; RAT; SIGNAL TRANSDUCTION; SUMOYLATION; UBIQUITINATION;

CELL LINE, TUMOR; GENE EXPRESSION REGULATION; HUMANS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, ARYL HYDROCARBON; SUMO-1 PROTEIN; SUMOYLATION; TETRACHLORODIBENZODIOXIN; UBIQUITINATION;

EID: 84865424095     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24092     Document Type: Article

References (53)

1. Akintobi AM, Villano CM, White LA. 2007. 2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin (TCDD) exposure of normal human dermal fibroblasts results in AhR-dependent and -independent changes in gene expression. Toxicol Appl Pharmacol 220: 9-17.
2. Amakura Y, Tsutsumi T, Nakamura M, Kitagawa H, Fujino J, Sasaki K, Toyoda M, Yoshida T, Maitani T. 2003. Activation of the aryl hydrocarbon receptor by some vegetable constituents determined using in vitro reporter gene assay. Biol Pharm Bull 26: 532-539.
3. Barhoover MA, Hall JM, Greenlee WF, Thomas RS. 2010. Aryl hydrocarbon receptor regulates cell cycle progression in human breast cancer cells via a functional interaction with cyclin-dependent kinase 4. Mol Pharmacol 77: 195-201.
4. Capili AD, Lima CD. 2007. Structure and analysis of a complex between SUMO and Ubc9 illustrates features of a conserved E2-Ubl interaction. J Mol Biol 369: 608-618.
5. Degner SC, Papoutsis AJ, Selmin O, Romagnolo DF. 2009. Targeting of aryl hydrocarbon receptor-mediated activation of cyclooxygenase-2 expression by the indole-3-carbinol metabolite 3, 3'-diindolylmethane in breast cancer cells. J Nutr 139: 26-32.
6. Diani-Moore S, Labitzke E, Brown R, Garvin A, Wong L, Rifkind AB. 2006. Sunlight generates multiple tryptophan photoproducts eliciting high efficacy CYP1A induction in chick hepatocytes and in vivo. Toxicol Sci 90: 96-110.
7. DuSell CD, Nelson ER, Wittmann BM, Fretz JA, Kazmin D, Thomas RS, Pike JW, McDonnell DP. 2010. Regulation of aryl hydrocarbon receptor function by selective estrogen receptor modulators. Mol Endocrinol 24: 33-46.
8. Fu C, Ahmed K, Ding H, Ding X, Lan J, Yang Z, Miao Y, Zhu Y, Shi Y, Zhu J, Huang H, Yao X. 2005. Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3. Oncogene 24: 5401-5413.
9. Gill G. 2003. Post-translational modification by the small ubiquitin-related modifier SUMO has big effects on transcription factor activity. Curr Opin Genet Dev 13: 108-113.
10. Gill G. 2004. SUMO and ubiquitin in the nucleus: Different functions, similar mechanisms? Genes Dev 18: 2046-2059.
11. Gong L, Yeh ET. 2006. Characterization of a family of nucleolar SUMO-specific proteases with preference for SUMO-2 or SUMO-3. J Biol Chem 281: 15869-15877.
12. Gong L, Millas S, Maul GG, Yeh ET. 2000. Differential regulation of sentrinized proteins by a novel sentrin-specific protease. J Biol Chem 275: 3355-3359.
13. Haarmann-Stemmann T, Bothe H, Abel J. 2009. Growth factors, cytokines and their receptors as downstream targets of arylhydrocarbon receptor (AhR) signaling pathways. Biochem Pharmacol 77: 508-520.
14. Hall JM, Barhoover MA, Kazmin D, McDonnell DP, Greenlee WF, Thomas RS. 2010. Activation of the aryl-hydrocarbon receptor inhibits invasive and metastatic features of human breast cancer cells and promotes breast cancer cell differentiation. Mol Endocrinol 24: 359-369.
15. Hong Y, Xing X, Li S, Bi H, Yang C, Zhao F, Liu Y, Ao X, Chang AK, Wu H. 2011. SUMOylation of DEC1 protein regulates its transcriptional activity and enhances its stability. PLoS ONE 6: e23046.
16. Hosoya T, Harada N, Mimura J, Motohashi H, Takahashi S, Nakajima O, Morita M, Kawauchi S, Yamamoto M, Fujii-Kuriyama Y. 2008. Inducibility of cytochrome P450 1A1 and chemical carcinogenesis by benzo[a]pyrene in AhR repressor-deficient mice. Biochem Biophys Res Commun 365: 562-567.
17. Ikuta T, Kobayashi Y, Kawajiri K. 2004a. Cell density regulates intracellular localization of aryl hydrocarbon receptor. J Biol Chem 279: 19209-19216.
18. Ikuta T, Kobayashi Y, Kawajiri K. 2004b. Phosphorylation of nuclear localization signal inhibits the ligand-dependent nuclear import of aryl hydrocarbon receptor. Biochem Biophys Res Commun 317: 545-550.
19. Ikuta T, Namiki T, Fujii-Kuriyama Y, Kawajiri K. 2009. AhR protein trafficking and function in the skin. Biochem Pharmacol 77: 588-596.
20. Itahana Y, Yeh ET, Zhang Y. 2006. Nucleocytoplasmic shuttling modulates activity and ubiquitination-dependent turnover of SUMO-specific protease 2. Mol Cell Biol 26: 4675-4689.
21. Jung JE, Moon JY, Ghil SH, Yoo BS. 2009. 2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin (TCDD) inhibits neurite outgrowth in differentiating human SH-SY5Y neuroblastoma cells. Toxicol Lett 188: 153-156.
22. Karvonen U, Jaaskelainen T, Rytinki M, Kaikkonen S, Palvimo JJ. 2008. ZNF451 is a novel PML body- and SUMO-associated transcriptional coregulator. J Mol Biol 382: 585-600.
23. Kerkvliet NI. 2009. AHR-mediated immunomodulation: The role of altered gene transcription. Biochem Pharmacol 77: 746-760.
24. Kim HS, Lee BM. 1997. Inhibition of benzo[a]pyrene-DNA adduct formation by Aloe barbadensis Miller. Carcinogenesis 18: 771-776.
25. Kim JY, Chung JY, Park JE, Lee SG, Kim YJ, Cha MS, Han MS, Lee HJ, Yoo YH, Kim JM. 2007. Benzo[a]pyrene induces apoptosis in RL 95-2. Human endometrial cancer cells by cytochrome P450 1A1 activation. Endocrinology 148: 5112-5122.
26. Knipscheer P, van Dijk WJ, Olsen JV, Mann M, Sixma TK. 2007. Noncovalent interaction between Ubc9 and SUMO promotes SUMO chain formation. EMBO J 26: 2797-2807.
27. Kumar MB, Ramadoss P, Reen RK, Vanden Heuvel JP, Perdew GH. 2001. The Q-rich subdomain of the human Ah receptor transactivation domain is required for dioxin-mediated transcriptional activity. J Biol Chem 276: 42302-42310.
28. Kung T, Murphy KA, White LA. 2009. The aryl hydrocarbon receptor (AhR) pathway as a regulatory pathway for cell adhesion and matrix metabolism. Biochem Pharmacol 77: 536-546.
29. Lehembre F, Muller S, Pandolfi PP, Dejean A. 2001. Regulation of Pax3 transcriptional activity by SUMO-1-modified PML. Oncogene 20: 1-9.
30. Li S, Yang C, Hong Y, Bi H, Zhao F, Liu Y, Ao X, Pang P, Xing X, Chang AK, Xiao L, Zhang Y, Wu H. 2012. The transcriptional activity of coactivator AIB1 is regulated by the SUMO E3 ligase PIAS1. Biol Cell 104: 287-296.
31. Lima CD, Reverter D. 2008. Structure of the human SENP7 catalytic domain and poly-SUMO deconjugation activities for SENP6 and SENP7. J Biol Chem 283: 32045-32055.
32. Ma Q, Baldwin KT. 2000. 2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin-induced degradation of aryl hydrocarbon receptor (AhR) by the ubiquitin-proteasome pathway. Role of the transcription activaton and DNA binding of AhR. J Biol Chem 275: 8432-8438.
33. Matic I, van Hagen M, Schimmel J, Macek B, Ogg SC, Tatham MH, Hay RT, Lamond AI, Mann M, Vertegaal AC. 2008. In vivo identification of human small ubiquitin-like modifier polymerization sites by high accuracy mass spectrometry and an in vitro to in vivo strategy. Mol Cell Proteomics 7: 132-144.
34. Meyer BK, Perdew GH. 1999. Characterization of the AhR-hsp90-XAP2 core complex and the role of the immunophilin-related protein XAP2 in AhR stabilization. Biochemistry 38: 8907-8917.
35. Morris JR, Boutell C, Keppler M, Densham R, Weekes D, Alamshah A, Butler L, Galanty Y, Pangon L, Kiuchi T, Ng T, Solomon E. 2009. The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress. Nature 462: 886-890.
36. Mukherjee S, Thomas M, Dadgar N, Lieberman AP, Iniguez-Lluhi JA. 2009. Small ubiquitin-like modifier (SUMO) modification of the androgen receptor attenuates polyglutamine-mediated aggregation. J Biol Chem 284: 21296-21306.
37. Muller S, Matunis MJ, Dejean A. 1998. Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J 17: 61-70.
38. Nair S, Kekatpure VD, Judson BL, Rifkind AB, Granstein RD, Boyle JO, Subbaramaiah K, Guttenplan JB, Dannenberg AJ. 2009. UVR exposure sensitizes keratinocytes to DNA adduct formation. Cancer Prev Res (Phila) 2: 895-902.
39. Ohtake F, Fujii-Kuriyama Y, Kawajiri K, Kato S. 2011. Cross-talk of dioxin and estrogen receptor signals through the ubiquitin system. J Steroid Biochem Mol Biol 127: 102-107.
40. Oshima M, Mimura J, Sekine H, Okawa H, Fujii-Kuriyama Y. 2009. SUMO modification regulates the transcriptional repressor function of aryl hydrocarbon receptor repressor. J Biol Chem 284: 11017-11026.
41. Pascual G, Fong AL, Ogawa S, Gamliel A, Li AC, Perissi V, Rose DW, Willson TM, Rosenfeld MG, Glass CK. 2005. A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature 437: 759-763.
42. Petrulis JR, Perdew GH. 2002. The role of chaperone proteins in the aryl hydrocarbon receptor core complex. Chem Biol Interact 141: 25-40.
43. Pongratz I, Stromstedt PE, Mason GG, Poellinger L. 1991. Inhibition of the specific DNA binding activity of the dioxin receptor by phosphatase treatment. J Biol Chem 266: 16813-16817.
44. Remillard RB, Bunce NJ. 2002. Linking dioxins to diabetes: Epidemiology and biologic plausibility. Environ Health Perspect 110: 853-858.
45. Safe SH. 1995. Modulation of gene expression and endocrine response pathways by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin and related compounds. Pharmacol Ther 67: 247-281.
46. Tan Z, Chang X, Puga A, Xia Y. 2002. Activation of mitogen-activated protein kinases (MAPKs) by aromatic hydrocarbons: Role in the regulation of aryl hydrocarbon receptor (AHR) function. Biochem Pharmacol 64: 771-780.
47. Tojo M, Matsuzaki K, Minami T, Honda Y, Yasuda H, Chiba T, Saya H, Fujii-Kuriyama Y, Nakao M. 2002. The aryl hydrocarbon receptor nuclear transporter is modulated by the SUMO-1 conjugation system. J Biol Chem 277: 46576-46585.
48. Vezina CM, Lin TM, Peterson RE. 2009. AHR signaling in prostate growth, morphogenesis, and disease. Biochem Pharmacol 77: 566-576.
49. Wang H, Zhao Y, Li L, McNutt MA, Wu L, Lu S, Yu Y, Zhou W, Feng J, Chai G, Yang Y, Zhu WG. 2008. An ATM- and Rad3-related (ATR) signaling pathway and a phosphorylation-acetylation cascade are involved in activation of p53/p21Waf1/Cip1 in response to 5-aza-2'-deoxycytidine treatment. J Biol Chem 283: 2564-2574.
50. Wu H, Sun L, Zhang Y, Chen Y, Shi B, Li R, Wang Y, Liang J, Fan D, Wu G, Wang D, Li S, Shang Y. 2006. Coordinated regulation of AIB1 transcriptional activity by sumoylation and phosphorylation. J Biol Chem 281: 21848-21856.
51. Yang SH, Galanis A, Witty J, Sharrocks AD. 2006. An extended consensus motif enhances the specificity of substrate modification by SUMO. EMBO J 25: 5083-5093.
52. Yeh ET. 2009. SUMOylation and de-SUMOylation: Wrestling with life's processes. J Biol Chem 284: 8223-8227.
53. Zhang S, Qin C, Safe SH. 2003. Flavonoids as aryl hydrocarbon receptor agonists/antagonists: Effects of structure and cell context. Environ Health Perspect 111: 1877-1882.